Chairman, Department of Cell Biology, Vice
Chair for Translational Research, Lerner Research Institute,
Cleveland Clinic; Professor of Molecular Medicine, Case School of
Medicine
Dr. Silverstein received his undergraduate degree in Biology
from Brown University and his Medical degree from Emory University.
After completing clinical training in Internal Medicine, Hematology
and Medical Oncology at New York Hospital-Cornell Medical Center in
Manhattan he joined the faculty at Cornell where he spent nearly 20
years, rising through the ranks to Professor of Medicine and Chair
of the Division of Hematology/Oncology. Dr. Silverstein joined the
Cleveland Clinic in April, 2004 as Chair of the Department of Cell
Biology and Vice Chair of the Lerner Research Institute. Under his
leadership the Department has grown to 21 independent principal
investigators and more than 100 support staff engaged in cutting
edge biomedical research and education. His own research focuses on
the molecular and cellular basis of human vascular diseases,
including thrombosis, atherosclerosis, and cancer-associated
angiogenesis. He is director of the NIH-funded Cleveland Clinic
Specialized Center of Clinically Oriented Research (SCCOR) in
Thrombosis and an NIH-funded program project on vascular
pathobiology. Dr. Silverstein is very active in medical and PhD
education, serving as part of the leadership team of the Cleveland
Clinic Lerner College of Medicine and as a PhD trainer for Case
Graduate School and Cleveland State University. On a national
level, Dr. Silverstein has chaired multiple NIH, American Heart
Association, Howard Hughes Medical Institute and Veteran’s
Administration grant review panels, as well as national conferences
on research into blood and vascular diseases. He has published over
100 articles in his field and serves on the editorial board of
several prestigious scientific journals. He is an elected member of
the American Society of Clinical Investigation and the Association
of American Physicians and has served as President of the American
Society for Clinical Research. He is currently Chair of the
Government Affairs Committee for the American Society of
Hematology.